Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laith J Abu-Raddad

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
BMJ Innovations|June 30, 2021
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analysesHoussein H Ayoub, Hiam Chemaitelly, Monia Makhoul, et al.
Nature|February 5, 2025
Differential protection against SARS-CoV-2 reinfection pre- and post-OmicronHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Vaccine|July 30, 2025
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over timeHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Elife|June 9, 2025
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Scientific Reports|October 8, 2025
Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMC Infectious Diseases|August 17, 2025
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide studyHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses|September 29, 2024
BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Journal of Medical Microbiology|May 16, 2022
Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settingsPeter V Coyle, Naema Hassan Al Molawi, Mohamed Ali Ben Hadj Kacem, et al.
Frontiers in Medicine|March 26, 2024
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimationHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Plos One|September 26, 2025
Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysisHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
BMJ Innovations|June 30, 2021
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analysesHoussein H Ayoub, Hiam Chemaitelly, Monia Makhoul, et al.
Nature|February 5, 2025
Differential protection against SARS-CoV-2 reinfection pre- and post-OmicronHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Vaccine|July 30, 2025
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over timeHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Elife|June 9, 2025
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Scientific Reports|October 8, 2025
Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMC Infectious Diseases|August 17, 2025
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide studyHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Influenza and Other Respiratory Viruses|September 29, 2024
BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in QatarHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Journal of Medical Microbiology|May 16, 2022
Reporting of RT-PCR cycle threshold (Ct) values during the first wave of COVID-19 in Qatar improved result interpretation in clinical and public health settingsPeter V Coyle, Naema Hassan Al Molawi, Mohamed Ali Ben Hadj Kacem, et al.
Frontiers in Medicine|March 26, 2024
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimationHiam Chemaitelly, Houssein H Ayoub, Patrick Tang, et al.
Plos One|September 26, 2025
Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysisHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Pageof 32